UCB Advances Two-Drug Strategy For Myasthenia Gravis

 
• By Joseph Haas
  
UCB flag
UCB posts second successful Phase III trial in gMG in two months • Source: UCB
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D